Amarin Corp PLC (AMRN) Q3 2024 Earnings Call Highlights: Navigating Revenue Declines Amid ...

Amarin's Q3 Earnings In Line, Revenues Fall Shy of Estimates

Amarin Plc (AMRN) Q3 2024 Earnings Call Transcript

Amarin: Q3 Earnings Snapshot

Amarin Reports Third Quarter 2024 Financial Results and Provides Business Update

Amarin Corp PLC (AMRN) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...

Amarin Announces Two Upcoming Investor Events

Here's Why We're Not At All Concerned With Amarin's (NASDAQ:AMRN) Cash Burn Situation

Research Highlighting the Clinical Impact of VASCEPA®/VAZKEPA (icosapent ethyl) in Patients with Diabetes and High Cardiovascular Risk and the Anti-Lp(a) Oxidation Mechanistic Effect of Eicosapentaenoic Acid (EPA) to be Presented at the 60th Annual Eu...

Latest Research Highlighting VASCEPA®/VAZKEPA® (icosapent ethyl) REDUCE-IT® Subgroup Data and New Mechanistic Insights into Eicosapentaenoic Acid (EPA) to be Presented at European Society of Cardiology (ESC) Congress

Exploring 3 Undervalued Small Caps In United States With Insider Action

Amarin (AMRN) Stock Down Despite Q2 Earnings & Revenues Beat